Korean J Pancreas Biliary Tract.  2017 Oct;22(4):153-157. 10.15279/kpba.2017.22.4.153.

Drug Induced Acute Pancreatitis

• Kim YS
• Cho JH

• KMID: 2448611
• DOI: http://doi.org/10.15279/kpba.2017.22.4.153

Abstract

Drug induced acute pancreatitis (AP) is considered a relative rare disease. It has no distinguishing clinical features and physician may ignore the possibility of that due to lack of clinical recognition. Although estimates of the relative frequency with which drugs causes AP vary widely, there is a difficulty in proving the causal relationship between drug and pancreatitis. Therefore, a careful history taking and high index of suspicion is required for making a correct diagnosis. Drug induced AP is classified (class I-IV) based on previous literatures demonstrating the latent period and rechallenge reaction. Generally, class I and II drugs have the greatest potential for causing AP. In conclusion, physicians should be more aware of the possibility of drug induced AP in patients with unexplained AP and treat appropriately by discontinuation of the offending drugs. Besides, well designed epidemiological studies are needed to better define the frequency and specific risk of pancreatitis associated with any individual drug in Korea.

Keyword

Pancreatitis; Pharmaceutical preparations; Prescriptions

MeSH Terms

Diagnosis
Epidemiologic Studies
Humans
Korea
Pancreatitis*
Pharmaceutical Preparations
Prescriptions
Rare Diseases
Pharmaceutical Preparations